Proxy Votes Now

Home › Funds › Brandes Global Equity Fund

Brandes Global Equity Fund (BGEAX) proxy voting record 2025-2026

Fund family: Datum One Series Trust · Filed by Datum One Series Trust (CIK 1806095) · SEC series S000084887

Share classes and tickers: BGEAX (C000249532), BGVCX (C000249533), BGVIX (C000249534), BGVRX (C000249531)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,080 with, 35 against, 0 abstentions (not counted as with management); 18 items carried no recommendation. Shareholder proposals: 10 FOR, 25 AGAINST, 0 abstained, by the filing’s own vote-source field.

Where this fund voted differently from most Datum One Series Trust funds

Each ballot item this fund voted is set against the votes of the other Datum One Series Trust funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most Datum One Series Trust funds on all 40 items where a comparison was possible.

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5930
Corporate Governance1579
Capital Structure1341
Compensation1130
Audit-related720
Say-on-Pay310
Other Social Issues138
Shareholder Rights and Defenses108
Environment or Climate55
Extraordinary Transactions20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Micron Technology, Inc.January 15, 2026$3M121
The Cigna GroupApril 22, 2026$2M151
Merck & Co., Inc.May 26, 2026$2M183
Citigroup Inc.May 20, 2026$2M160
Textron Inc.April 29, 2026$2M130
UnitedHealth Group IncorporatedJune 1, 2026$2M121
Becton, Dickinson and CompanyJanuary 27, 2026$2M160
Pfizer Inc.April 23, 2026$2M161

Notable votes against management

MeetingCompanyProposalFundMgmt
January 15, 2026Micron Technology, Inc.Shareholder Proposal Requesting Amendment To Shareholder Special Meeting Right. Shareholder proposalForAgainst
April 22, 2026The Cigna GroupShareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposalForAgainst
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalForAgainst
April 23, 2026Pfizer Inc.Adopt an Independent Chair Policy Shareholder proposalForAgainst
May 21, 2026EPAM Systems, Inc.To hold an advisory vote on a stockholder proposal, entitled ""Give Shareholders an Ability to Call for a Special Shareholder Meeting."" Shareholder proposalForAgainst
May 4, 2026Bank of America CorporationShareholder proposal requesting independent board chair Shareholder proposalAgainstFor
May 4, 2026Bank of America CorporationShareholder proposal requesting report on board oversight of risks related to animal welfare Shareholder proposalAgainstFor
April 28, 2026Wells Fargo & CompanyShareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair. Shareholder proposalAgainstFor
April 28, 2026Wells Fargo & CompanyShareholder Proposal - Govern by Majority Vote. Shareholder proposalAgainstFor
June 10, 2026Comcast CorporationAdopt policy to have an independent chair Shareholder proposalForAgainst

Search this fund’s votes by company

1,134 ballot items at 71 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Brandes Global Equity Fund (BGEAX) voted at 71 shareholder meetings of 67 companies, on 1,134 ballot items in all. Where management made a recommendation, the fund followed it on 96.9% of the items and voted against it 35 times. Its most frequent area of disagreement was corporate governance (9 of its votes against management). It voted on 35 shareholder proposals. It voted the same way as most Datum One Series Trust funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.